Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 25, 2022

Investigational Drug Information for Mitoquinone

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Mitoquinone?

Mitoquinone is an investigational drug.

There have been 9 clinical trials for Mitoquinone. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1^st 2006.

The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., University of Colorado, Boulder, and MitoQ Ltd.

Summary for Mitoquinone

US Patents	0
International Patents	0
US Patent Applications	38
WIPO Patent Applications	9
Japanese Patent Applications	4
Clinical Trial Progress	Phase 2 (2006-05-01)
Vendors	12

Recent Clinical Trials for Mitoquinone

Title	Sponsor	Phase
An Open Label Study in Healthy Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate as Prophylaxis for Development of Severe Viral Illness	University of California, Los Angeles	Phase 1/Phase 2
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients	InCor Heart Institute	N/A
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients	Instituto do Cancer do Estado de São Paulo	N/A

See all Mitoquinone clinical trials

Clinical Trial Summary for Mitoquinone

Top disease conditions for Mitoquinone

Top clinical trial sponsors for Mitoquinone

See all Mitoquinone clinical trials

US Patents for Mitoquinone

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Baxter

McKinsey

Harvard Business School

Mallinckrodt

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.